Document is current
Any future updates will be listed below
-
Authors
Ibruli, Olta
Rose, France
Beleggia, Filippo
Schmitt, Anna
Cartolano, Maria
Fernandez, Lucia Torres
Saggau, Julia
Bonasera, Debora
Kiljan, Martha
Gozum, Gokcen
Lichius, Luca
Cai, Jiali
Niu, Li-na
Caiaffa, Manoela Iannicelli
Herter, Jan M.
Walczak, Henning
Liccardi, Gianmaria
Grüll, Holger
Büttner, Reinhard
Bosco, Graziella
George, Julie
Thomas, Roman K.
Bozek, Kasia
Reinhardt, Hans Christian
Herter-Sprie, Grit S.
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (413326622)
Deutsche Krebshilfe (1117240)
Mildred Scheel Nachwuchszentrum (70113307)
Center for Molecular Medicine Cologne, University of Cologne (CAP-13, CAP-16)
Deutsche Forschungsgemeinschaf (424228829)
Deutsche Forschungsgemeinschaf (455784452)
Alexander von Humboldt-Stiftung (214342/Z/18/Z)
Medical Research Council (MR/S00811X/1)
Cancer Research UK Programme (A27323)
Center for Biochemistry, Univeristy of Cologne (956400)
CANcer TARgeting (NW21-062A)
German Ministry of Education and Research (01ZX1901)
Else Kröner-Fresenius-Stiftung (EKFS-2014-A06)
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Received: 5 July 2024
Accepted: 4 September 2024
First Online: 14 November 2024
Declarations
:
: H.C.R. received consulting and lecture fees from Abbvie, AstraZeneca, Vertex, and Merck. H.C.R. received research funding from AstraZeneca and Gilead Pharmaceuticals. H.C.R. is a co-founder of CDL Therapeutics GmbH. R.K.T. is a founder of Disco Pharmaceuticals GmbH, PearlRiver Bio (now part of Centessa), a shareholder of Centessa, founder and shareholder of Epiphanes Inc. and a consultant to PearlRiver Bio and Epiphanes Inc. R.K.T. has received research support from Roche. The remaining authors declare no competing financial interest.
: Animal experiments in this study were approved by the local Ethics Committee of Animal Experiments authorities (LANUV, North Rhine-Westphalia, Germany) under license number 81-02.04.2019-A491. All mice were maintained according to FELASA recommendations and in compliance with the European Union and German guidelines.
